Ekkehard Moessner

1.6k total citations
20 papers, 614 citations indexed

About

Ekkehard Moessner is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Molecular Biology. According to data from OpenAlex, Ekkehard Moessner has authored 20 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Ekkehard Moessner's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Glycosylation and Glycoproteins Research (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Ekkehard Moessner is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Glycosylation and Glycoproteins Research (6 papers) and Radiopharmaceutical Chemistry and Applications (5 papers). Ekkehard Moessner collaborates with scholars based in Switzerland, Germany and United Kingdom. Ekkehard Moessner's co-authors include Pablo Umaña, Christian Klein, Claudia Baumgartner, Jens Niewoehner, Hadassah Sade, Per‐Ola Freskgård, Ralf J. Hosse, Anne Freimoser–Grundschober, Inja Waldhauer and Thomas Friess and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Ekkehard Moessner

19 papers receiving 598 citations

Peers

Countries citing papers authored by Ekkehard Moessner

Since Specialization

Citations

This map shows the geographic impact of Ekkehard Moessner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ekkehard Moessner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ekkehard Moessner more than expected).

Fields of papers citing papers by Ekkehard Moessner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ekkehard Moessner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ekkehard Moessner. The network helps show where Ekkehard Moessner may publish in the future.

Co-authorship network of co-authors of Ekkehard Moessner

This figure shows the co-authorship network connecting the top 25 collaborators of Ekkehard Moessner. A scholar is included among the top collaborators of Ekkehard Moessner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ekkehard Moessner. Ekkehard Moessner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Co-expression of an adapter CAR retains efficacy of CAR T cells after single and dual antigen loss in lymphoma 2025 ·Molecular Therapy ·Zeno Riester, (unknown), Nicole Seifert, (unknown), Arindam Ghosh, (unknown), Justus Weber, Reto Gianotti, (unknown), Miriam Alb, Thomas Nerreter, Elena Hartmann, Andreas Rosenwald, Markus Sauer, Ekkehard Moessner, Hermann Einsele, Claudia Ferrara, Christian Klein, (unknown), Sophia Danhof	0
2	Characterization of anti-drug antibody responses to the T-cell engaging bispecific antibody cibisatamab to understand the impact on exposure 2024 ·Frontiers in Immunology ·Gregor P. Lotz, (unknown), Meret Martin‐Facklam, (unknown), Eginhard Schick, Ekkehard Moessner, (unknown), (unknown), (unknown), Ralf J. Hosse, Anne Freimoser–Grundschober, Christian Klein, Martin Schäfer, Mirko Ritter, Kay‐Gunnar Stubenrauch	1
3	Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies enable modular targeting of solid tumors 2022 ·Journal for ImmunoTherapy of Cancer ·Sophia Stock, Mohamed-Reda Benmebarek, (unknown), (unknown), Christian Jöst, Kay‐Gunnar Stubenrauch, J. Benz, Anne Freimoser–Grundschober, Ekkehard Moessner, Pablo Umaña, Marion Subklewe, Stefan Endres, Christian Klein, Sebastian Kobold	19
4	Surprisingly Fast Interface and Elbow Angle Dynamics of Antigen-Binding Fragments 2020 ·Frontiers in Molecular Biosciences ·Monica L. Fernández‐Quintero, (unknown), (unknown), Johannes R. Loeffler, Patrick K. Quoika, Franz Waibl, Alexander Bujotzek, Ekkehard Moessner, Guy Georges, Klaus R. Liedl	20
5	Abstract LB-389: Combination of TYRP1-TCB, a novel T cell bispecific antibody for the treatment of melanoma, with immunomodulatory agents 2020 ·Cancer Research ·Valeria Nicolini, Inja Waldhauer, Anne Freimoser–Grundschober, Marine Richard, Linda Fahrni, Esther Bommer, Christina Claus, Johannes Sam, Sara Colombetti, Roger P.M. Sutmuller, Mitchell P. Levesque, Anja Irmisch, Conrad C. Bleul, (unknown), Marina Bacac, Ekkehard Moessner, Christian Klein, Pablo Umaña	6
6	A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease 2018 ·Journal of Autoimmunity ·Laurence B. Peterson, (unknown), Sarah Howlett, Marcin Ł. Pękalski, Kevin Brady, Heather Hinton, (unknown), John A. Todd, Pablo Umaña, Oliver Ast, Inja Waldhauer, Anne Freimoser–Grundschober, Ekkehard Moessner, Christian Klein, Ralf J. Hosse, Linda S. Wicker	104
7	XGFR, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer 2016 ·mAbs* ·(unknown), Katharina Wartha, Ekkehard Moessner, Ralf J. Hosse, Samuel Moser, Rebecca Croasdale, (unknown), (unknown), Peng Wang, Lei Shi, Tina Weinzierl, Natascha Rieder, Marina Bacac, Carola H. Ries, Hubert Kettenberger, Tilman Schlothauer, Thomas Friess, Pablo Umaña, Christian Klein	27
8	Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti–Fibroblast Activation Protein Antibody Correlates with Severity of Arthritis 2015 ·Journal of Nuclear Medicine ·Peter Laverman, (unknown), Samantha Y.A. Terry, Danny Gerrits, Birgitte Walgreen, Monique M. Helsen, Tapan K. Nayak, Anne Freimoser–Grundschober, Inja Waldhauer, Ralf J. Hosse, Ekkehard Moessner, Pablo Umaña, Christian Klein, Wim J.G. Oyen, Marije I. Koenders, Otto C. Boerman	86
9	Abstract 2481: CEA TCB, a novel T-cell bispecific antibody with potent in vitro and in vivo antitumor activity against solid tumors 2015 ·Cancer Research ·Marina Bacac, Tanja Fauti, Sara Colombetti, Johannes Sam, Valeria Nicolini, Nathalie Steinhoff, Oliver Ast, Peter Bruenker, Ralf J. Hosse, Thomas Höfer, Ekkehard Moessner, (unknown), Jose Saro, Vaios Karanikas, Christian Klein, Pablo Umaña	1
10	Abstract 2460: Dissecting the in vitro and in vivo mechanism of action of obinutuzumab (GA101) in preclinical models using an immune effector-dead version of obinutuzumab 2015 ·Cancer Research ·Sylvia Herter, Frank Herting, Gunter Muth, Erwin van Puijenbroek, Claudia Ferrara, Sabine M. Lang, Marina Bacac, Ekkehard Moessner, Pablo Umaña, Christian Klein	1
11	ITOC2 – 037. CEA TCB, A novel T-cell bispecific antibody with potent in vitro and in vivo antitumour activity against solid tumours 2015 ·European Journal of Cancer ·Marina Bacac, Tanja Fauti, Sara Colombetti, Johannes Sam, Valeria Nicolini, Nathalie Steinhoff, Oliver Ast, Peter Bruenker, Ralf J. Hosse, Thomas Höfer, Ekkehard Moessner, (unknown), Jose Saro, Vaios Karanikas, Christian Klein, Pablo Umaña	1
12	Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells 2014 ·Journal of Autoimmunity ·(unknown), Yongliang Sun, (unknown), Jan Clark, Sarah Howlett, Marcin Ł. Pękalski, Xin Yang, Oliver Ast, Inja Waldhauer, Anne Freimoser–Grundschober, Ekkehard Moessner, Pablo Umaña, Christian Klein, Ralf J. Hosse, Linda S. Wicker, Laurence B. Peterson	69
13	A Human Blood-Brain Barrier Transcytosis Assay Reveals Antibody Transcytosis Influenced by pH-Dependent Receptor Binding 2014 ·PLoS ONE ·Hadassah Sade, Claudia Baumgartner, (unknown), Ekkehard Moessner, Per‐Ola Freskgård, Jens Niewoehner	113
14	GA201 (RG7160): A Novel, Humanized, Glycoengineered Anti-EGFR Antibody with Enhanced ADCC and Superior In Vivo Efficacy Compared with Cetuximab 2012 ·Clinical Cancer Research ·Christian A. Gerdes, Valeria Nicolini, Sylvia Herter, Erwin van Puijenbroek, Sabine M. Lang, (unknown), Ekkehard Moessner, (unknown), Thomas Friess, Carola H. Ries, Birgit Bossenmaier, (unknown), Pablo Umaña	98
15	Abstract 2508: GE-huMab-HER3, a novel humanized, glycoengineered HER3 antibody with enhanced ADCC and superior preclinical in vitro and in vivo efficacy 2012 ·Cancer Research ·Birgit Bossenmaier, Thomas Friess, Christian Gerdes, (unknown), (unknown), Valeria Lifke, (unknown), Ekkehard Moessner, (unknown), Thomas von Hirschheydt, Helmut Burtscher, Gerhard Niederfellner	3
16	Crystal Structure Analysis Reveals That the Novel Type II Anti-CD20 Antibody GA101 Interacts with a Similar Epitope as Rituximab and Ocrelizumab but in a Fundamentally Different Way. 2009 ·Blood ·Gerhard Niederfellner, Alfred Lammens, Manfred Schwaiger, Guy Georges, (unknown), Andreas G. Franke, Wolfgang Schaefer, Stefan Jenewein, Jerry W. Slootstra, Ekkehard Moessner, Pablo Umaña, Karl‐Peter Hopfner, Christian Klein	11
17	GA201, a novel humanized, glycoengineered EGFR antibody with enhanced ADCC and superior in vivo efficacy in xenograft models 2008 ·Cancer Research ·Christian Gerdes, Monika Patre, Valeria Nicolini, Ekkehard Moessner, (unknown), Peter Bruenker, Samuel Moser, Roger Grau, Carla Schmidt, Barbara Guarino, Peter Sondermann, (unknown), Susanne Preiß, Erwin van Puijenbroek, Birgit Bossenmaier, Carola H. Ries, Thomas Friess, Pablo Umaña	3
18	504 POSTER GA101, a therapeutic glycoengineered CD20 antibody recognizing a type II epitope mediates outstanding anti-tumor efficacy in Non-Hodgkin lymphoma xenograft models and superior B cell depletion 2008 ·European Journal of Cancer Supplements ·Christian Klein, Frank Herting, Thomas Friess, Christian Gerdes, Adam Nopora, S. P. Bauer, Roger Grau, Ekkehard Moessner, Joseph Dal Porto, Pablo Umaña	2
19	Novel 3rd Generation Humanized Type II CD20 Antibody with Glycoengineered Fc and Modified Elbow Hinge for Enhanced ADCC and Superior Apoptosis Induction. 2006 ·Blood ·Pablo Umaña, Ekkehard Moessner, Peter Bruenker, (unknown), (unknown), Tobias Suter, Roger Grau, Carla Schmidt, Christian Gerdes, Adam Nopora, Monika Patre, Samuel Moser, Peter Sondermann, (unknown), Martin J.S. Dyer, Sibrand Poppema, Sabine Bauer, (unknown), Thomas Friess, Christian Klein	44
20	[Immunohistochemistry: theoretical potentials and practical application]. 1985 ·PubMed ·Péter Fritz, J. Müller, (unknown), U. Braun, (unknown), (unknown), Ekkehard Moessner, (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact